Supporters of New Classification of Diabetes

In part seven of this special interview with DIC publisher Steve Freed, Dr. Stanley Schwartz discusses the supporters of the new classification of diabetes, such as the role of SGLT-2 inhibitors in improving cardiovascular outcomes, reducing weight, and targeting treatments for the mediating pathways of hyperglycemia.

View the complete video series of this special interview with Dr. Schwartz:

Part 1: Defining the Classifications of the New System

Part 2: Beta-Cell Construct: Egregious Eleven

Part 3: Targeted Treatments for Mediating Pathways of Hyperglycemia

Part 4: Individualization of Patient Care

Part 5: The Beta-Cell is Final Common Denominator of Beta-Cell Damage

Part 6: New Classification for Monogenic and Pre-Diabetes

Part 7: Supporters of New Classification of Diabetes

You can find all of Dr. Schwartz’s Diabetes In Control articles and videos as well as his biography here.